Funding
Turn ideas into impact
Show Me
Due: January 6, 2028
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-057
Due: January 7, 2028
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-068
Due: January 7, 2028
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
US $375,000
Type
Grant
Source
Federal
Opp Number
PAR-25-298
Due: January 7, 2028
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-281
Due: January 7, 2028
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk
US $275,000
Type
Grant
Source
Federal
Due: January 7, 2028
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAS-25-073
Due: January 7, 2028
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
US $50,000
Type
Grant
Source
Federal
Opp Number
PA-25-126
Due: January 7, 2028
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-202
Due: January 7, 2028
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-207
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?